60 DEGREES PHARMACEUTICALS, INC. (CIK: 0001946563) EDGAR, Information, Filings... CompaniesBIO.Com

60 DEGREES PHARMACEUTICALS, INC.

Mailing address
1025 CONNECTICUT AVENUE NW, SUITE 1000, WASHINGTON, Delaware, 20036
Phone
202-327-5422
State location
DC
State of incorporation
Delaware
Fiscal year end
December 31
SIC
2834 - (CF Office: Office of Life Sciences) PHARMACEUTICAL PREPARATIONS
Filings
N/A

60 DEGREES PHARMACEUTICALS, INC. (CIK: 0001946563) is an American company incorporated in the state of DC. Head office is located at 1025 CONNECTICUT AVENUE NW, SUITE 1000, WASHINGTON, DC, 20036. Work in the industry 2834 - (CF Office: Office of Life Sciences) PHARMACEUTICAL PREPARATIONS. 60 DEGREES PHARMACEUTICALS, INC. is a public company and trade via Over-The-Counter (OTC).

Owner	Filings	Transaction Date	Type of Owner
Allen Charles W	0001599502	Jul-11-2023	director
KENTUCKY TECHNOLOGY INC.	0001976955	Jul-11-2023	10 percent owner
XU CHERYL	0001976957	Jul-11-2023	director
FIELD PAUL	0001976960	Jul-11-2023	director
MILLER TYRONE	0001976962	Jul-11-2023	officer: Chief Financial Officer
DOW GEOFFREY S	0001977231	Jul-11-2023	director, 10 percent owner, officer: CEO and President
Florida State University Research Foundation Inc.	0001977695	Jul-11-2023	10 percent owner
SMITH BRYAN LEE	0001978153	Jul-11-2023	officer: Chief Medical Officer
TOOVEY STEPHEN	0001978935	Jul-11-2023	director

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by 60 DEGREES PHARMACEUTICALS, INC.

Filings	Format	Description	Filed/Effective	File/Film Number
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001213900-24-101110 ( Act) Size: 0 KB	Nov-21-2024
SC 13G	Document	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001172661-24-005107 (34 Act) Size: KB	Nov-14-2024	005-94258 241461114
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001213900-24-098195 (34 Act) Size: KB	Nov-14-2024	001-41719 241460051
SC 13G/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001213900-24-097440 (34 Act) Size: KB	Nov-13-2024	005-94258 241453845
8-K	Document	Current report filing Acc-no: 0001213900-24-095068 (34 Act) Size: KB	Nov-06-2024	001-41719 241432316
DEF 14A	Document	Definitive proxy statements Acc-no: 0001213900-24-087749 (34 Act) Size: KB	Oct-15-2024	001-41719 241371695
8-K	Document	Current report filing Acc-no: 0001213900-24-086079 (34 Act) Size: KB	Oct-08-2024	001-41719 241359238
PRE 14A	Document	Preliminary proxy statement not related to a contested matter or merger/acquisition Acc-no: 0001213900-24-084401 (34 Act) Size: KB	Oct-02-2024	001-41719 241345750
EFFECT	Document	Acc-no: 9999999995-24-003042 (33 Act) Size: KB	Sep-30-2024	333-282221 241341113
CORRESP	Document	A correspondence can be sent as a document with another submission type or can be sent as a separate submission. Acc-no: 0001213900-24-082339 ( Act) Size: KB	Sep-26-2024
UPLOAD	Document	Acc-no: 0000000000-24-010843 ( Act) Size: KB	Sep-24-2024	333-282221
S-3	Document	Registration statement for specified transactions by certain issuers Acc-no: 0001213900-24-080313 (33 Act) Size: KB	Sep-19-2024	333-282221 241310758
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001213900-24-077746 ( Act) Size: 0 KB	Sep-11-2024
8-K	Document	Current report filing Acc-no: 0001213900-24-076515 (34 Act) Size: KB	Sep-06-2024	001-41719 241284594
8-K	Document	Current report filing Acc-no: 0001213900-24-073351 (34 Act) Size: KB	Aug-28-2024	001-41719 241255197
8-K	Document	Current report filing Acc-no: 0001213900-24-068942 (34 Act) Size: KB	Aug-14-2024	001-41719 241207086
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001213900-24-068673 (34 Act) Size: KB	Aug-14-2024	001-41719 241205041
8-K	Document	Current report filing Acc-no: 0001213900-24-067535 (34 Act) Size: KB	Aug-12-2024	001-41719 241195749
424B5	Document	Prospectus filed pursuant to Rule 424(b)(5) Acc-no: 0001213900-24-064753 (33 Act) Size: KB	Aug-02-2024	333-280796 241171178
8-K	Document	Current report filing Acc-no: 0001013762-24-001604 (34 Act) Size: KB	Jul-26-2024	001-41719 241147076

Recent 20 filings. View all 60 DEGREES PHARMACEUTICALS, INC. filings

Overall rating 5.0

Aug 22, 2022

Ryan Storey

Huge help thank you for your help .. y'all make it so much easier

Aug 22, 2022

Samuel Ejimofor

It's being easier working on the website. And I recommend, it's a great website

Aug 22, 2022

Pelisari

young lad who new his job ansered questions and new what was best for me.

60 DEGREES PHARMACEUTICALS, INC. overview
60 DEGREES PHARMACEUTICALS, INC. job
60 DEGREES PHARMACEUTICALS, INC. stock
60 DEGREES PHARMACEUTICALS, INC. ownership
60 DEGREES PHARMACEUTICALS, INC. CEO
60 DEGREES PHARMACEUTICALS, INC. documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.